Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Jay Epstein, Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
28 Downloads (Pure)


Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in
low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized
quality standards should collect CCP.
Original languageEnglish
Article number103
Number of pages2
Journalnpj Vaccines
Issue number1
Publication statusPublished - 1-Dec-2020
Externally publishedYes

Cite this